Pharmaceutical Industry Information Portal

Roche offers molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants

Roche and TIB Molbiol, a subsidiary within the Roche Diagnostics division, announced available testing solutions that can identify the...

Italian Stevanato Group expands the boundaries by opening a manufacturing hub in China

The company Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology...

illumina launches multiple-gene test to spot rare treatable cancers

Illumina, Inc. today announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor...

MicroGEM’s PCR test, which gives results in 27 minutes, received EUA approval from FDA

MicroGEM has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the MicroGEM...

Sun Pharma shares up 4% after FDA approves mesalamine capsules

Sun Pharmaceutical Industries Limited, announced that it has received final approval from US FDA for its Abbreviated New Drug...

Lupin receives two FDA approvals and share price jumps

Global pharma major Lupin Ltd, May 06th, announced that it has received approval from the United States Food and...

Valneva shares drop 20% after deal with EU on COVID vaccine is broken

Shares of Valneva plunged 20% on Monday after the French drugmaker said its COVID-19 vaccine agreement with the European...

MicroGEM’s PCR test, which gives results in 27 minutes, received EUA approval from FDA

MicroGEM has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the MicroGEM...

Inventiva raises €50 million credit line from the European Investment Bank

Inventiva, a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients...

Don’t miss your daily PharmProm news.
SUBSCRIBE free here!

Combination of biomarkers discovered that can to identify subcortical small-vessel disease

In recent years, subcortical small-vessel disease has become an increasingly common cognitive diagnosis. Researchers at University of Gothenburg have...

New technologies are an integral part of diabetes management

A large population of people living with type 1 diabetes are set to be offered new technology to help...

EMA recommends approval of Spikevax for children aged 6 to 11

EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Spikevax to include...

MicroGEM’s PCR test, which gives results in 27 minutes, received EUA approval from FDA

MicroGEM has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the MicroGEM...

Yale, JDRF and NexImmune, $600,000 grant for diabetes research

NexImmune, Inc., Yale and JDRF have begun a two-year project to explore the use of NexImmune’s AIM nanoparticles in...

FDA lifts ban on LogicBio’s clinical trial on pediatric patients with methylmalonic acidemia

LogicBio Therapeutics, Inc., a clinical-stage company advancing a diversified pipeline of genetic medicines addressing rare disorders from infancy through...

Sales of AstraZeneca’s COVID vaccine exceed forecasts Q1 revenue $11.39 billion

AstraZeneca PLC said Friday that it expects sales of total revenue from COVID-19 medicines is anticipated to decline by...

Novo Nordisk raises 2022 outlook after strong quarter, shares up

Novo Nordisk targets higher sales and operating profit for the year on the back of projected profit growth in...

GSK shows strong sales performance in the first quarter of 2022 – £9.8 billion

British pharmaceutical giant GSK (GSK.L) on Wednesday beat analysts' expectations for its first-quarter results and reaffirmed its 2022 forecast. Highlights Strong...